Israeli maker of acid reflux device obtains $7M in financing

10/25/2013 | MassDevice.com (Boston)

A round of financing from U.S. and Israeli investors has pulled in $7 million for Medigus. The Israeli company, which has developed the FDA-cleared SRS Endoscopic device designed to treat gastroesophageal reflux disease less invasively, will use part of the money to accelerate its expansion efforts in Europe and the U.S.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY